LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

LENSAR (Nasdaq: LNSR) announced the granting of inducement awards to three newly-hired non-executive employees. The compensation package consists of an aggregate of 660 restricted stock units (RSUs), approved by the independent members of LENSAR's board of directors.

The RSUs were granted on July 1, 2025, under LENSAR's 2024 Employment Inducement Incentive Award Plan. Each RSU represents one share of common stock and will vest in four equal annual installments, contingent upon continued employment with the company through each vesting date.

ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an aggregate of 660 restricted stock units (“RSUs”). The RSUs were granted as of July 1, 2025, as inducement for each such employee commencing employment with the Company. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

Each RSU represents a contingent right to receive one share of the Company’s common stock. The RSUs vest in four substantially equal installments on each anniversary of the grant date, subject to the new employee’s continued service with the Company through the applicable vesting date. The RSUs are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a restricted stock unit agreement covering the grant.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.

Contacts:		Lee Roth / Cameron Radinovic
Thomas R. Staab, II, CFO		Burns McClellan for LENSAR
ir.contact@lensar.com		lroth@burnsmc.com / cradinovic@burnsmc.com

FAQ

What type of inducement grants did LENSAR (LNSR) announce on July 1, 2025?

LENSAR announced the granting of 660 restricted stock units (RSUs) to three newly-hired non-executive employees.

How do the LENSAR (LNSR) inducement RSUs vest?

The RSUs vest in four substantially equal installments on each anniversary of the July 1, 2025 grant date, subject to continued employment.

Under which plan were LENSAR's (LNSR) inducement grants awarded?

The RSUs were granted under LENSAR's 2024 Employment Inducement Incentive Award Plan and a restricted stock unit agreement.

Who approved LENSAR's (LNSR) inducement grants?

The grants were approved by a majority of the independent members of LENSAR's board of directors.